Dry powder measles vaccine: Particle deposition, virus replication, and immune response in cotton rats following inhalation

Vaccine

Volumn 29, Issue 5, 2011, Pages 905-912

  Kisich, Kevin O ^a   Higgins, Michael P ^a   Park, Insun ^a   Cape, Stephen P ^b   Lindsay, Lowry ^c   Bennett, David J ^e   Winston, Scott ^e   Searles, Jim ^e   Sievers, Robert E ^b,d,e  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b Cooperative Institute for Research in Environmental Sciences ^*  (United States)

^c UCB 450   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e Aktiv Dry LLC   (United States)

Author keywords

Aerosol; Cotton rat animal model; Dry powder; Measles vaccine

Indexed keywords

CARBON DIOXIDE; MEASLES VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; COTTON RAT; DRUG DELIVERY SYSTEM; DRUG POTENCY; DRUG STABILITY; DRY POWDER; IMMUNE RESPONSE; NEBULIZATION; NONHUMAN; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

ADMINISTRATION, INHALATION; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; FREEZE DRYING; INDIA; LUNG; MEASLES VACCINE; NEUTRALIZATION TESTS; PLAQUE ASSAY; POWDERS; SIGMODONTINAE; VACCINES, ATTENUATED; VIRUS REPLICATION;

EID: 78751566614     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.020     Document Type: Article

References (23)

1. Clements C.J., Nshimirimanda D., Gasasira A. Using immunization delivery strategies to accelerate progress in Africa towards achieving the Millennium Development Goals. Vaccine 2008, 26:1926-1933.
2. Paul Y. Oral polio vaccines and their role in polio eradication in India. Expert Rev Vaccines 2009, 8:35-41.
3. Low N., Kraemer S., Schneider M., Restrepo A.M. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis. Vaccine 2008, 26:383-398.
4. Dilraj A., Cutts F.T., de Castro J.F., Wheeler J.G., Brown D., Roth C., et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000, 355:798-803.
5. Cape S.P., Villa J.A., Huang E.T., Yang T.H., Carpenter J.F., Sievers R.E. Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids. Pharm Res 2008, 25:1967-1990.
6. Burger J.L., Cape S.P., Braun C.S., McAdams D.H., Best J.A., Bhagwat P., et al. Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine. J Aerosol Med Pulm Drug Deliv 2008, 21:25-34.
7. LiCalsi C., Maniaci M.J., Christenson T., Phillips E., Ward G.H., Witham C. A powder formulation of measles vaccine for aerosol delivery. Vaccine 2001, 19:2629-2636.
8. Cutts F.T., Clements C.J., Bennett J.V. Alternative routes of measles immunization: a review. Biologicals 1997, 25:323-338.
9. De Swart R.L., LiCalsi C., Quirk A.V., van Amerongen G., Nodelman V., Alcock R., et al. Measles vaccination of macaques by dry powder inhalation. Vaccine 2007, 25:1183-1190.
10. Simon J.K., Pasetti M.F., Viret J.F., Mischler R., Munoz A., Lagos R., et al. A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults. Hum Vaccin 2007, 3:54-58.
11. Wyde P.R., Ambrose M.W., Voss T.G., Meyer H.L., Gilbert B.E. Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proc Soc Exp Biol Med 1992, 201:80-87.
12. Wyde P.R., Stittelaar K.J., Osterhaus A.D., Guzman E., Gilbert B.E. Use of cotton rats for preclinical evaluation of measles vaccines. Vaccine 2000, 19:42-53.
13. Niewiesk S. Current animal models: cotton rat animal model. Curr Top Microbiol Immunol 2009, 330:89-110.
14. Ikic D., Juzbasic M., Beck M., Hrabar A., Cimbur-Schreiber T. Attenuation and characterisation of Edmonston-Zagreb measles virus. Ann Immunol Hung 1972, 16:175-181.
15. Cohen B.J., Audet S., Andrews N., Beeler J. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 2007, 26:59-66.
16. Finney D.J. Statistical method in biological assay 1964, Charles Griffin & Company Ltd., London, p. 524-30. 2nd ed.
17. Rebits L.G., Bennett D.J., Bhagwat P.A., Morin A., Sievers R.E. Method for quantifying the sample collected by an Andersen Cascade Impactor using total organic carbon analysis. J Aerosol Sci 2007, 38:1197-1206.
18. Forcic D., Kosutic-Gulija T., Santak M., Jug R., Ivancic-Jelecki J., Markusic M., et al. Comparisons of mumps virus potency estimates obtained by 50% cell culture infective dose assay and plaque assay. Vaccine 2010, 28:1887-1892.
19. Varmus H., Klausner R., Zerhouni E., Acharya T., Daar A.S., Singer P.A. Public health grand challenges in global health. Science 2003, 302:398-399.
20. Kemper C., Leung M., Stephensen C.B., Pinkert C.A., Liszewski M.K., Cattaneo R., et al. Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol 2001, 124:180-189.
21. Welstead G.G., Iorio C., Draker R., Bayani J., Squire J., Vongpunsawad S., et al. Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice. Proc Natl Acad Sci USA 2005, 102:16415-16420.
22. Wyde P.R., Moore-Poveda D.K., Daley N.J., Oshitani H. Replication of clinical measles virus strains in hispid cotton rats. Proc Soc Exp Biol Med 1999, 221:53-62.
23. Diamond G., Beckloff N., Ryan L.K. Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res 2008, 87:915-927.